戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 oposed links between liquid sugar energy and body weight change.
2                         The main outcome was body weight change.
3 rgy intake required to maintain a particular body-weight change.
4 h either treatment alone, with no effects on body weight changes.
5  no obvious behavioral abnormalities, and no body weight changes.
6  insulin resistance and bone metabolism, and body weight changes.
7 ope dilution (deuterium oxide) combined with body-weight changes.
8 in an obesogenic memory that defends against body weight changes(3,4).
9 on vs control group, greater improvements in body weight (change, -7.1 kg [95% CI, -8.6 to -5.5 kg] v
10                                              Body weight change and accelerometer-derived PA volume a
11        Dietary P and Pb interacted to affect body weight change and feed efficiency in mice.
12               Associations between prodromal body weight changes and blood lipids with risk of MCI at
13 Our model provides realistic calculations of body-weight change and of the dietary modifications requ
14 e was to determine ad libitum energy intake, body weight changes, and appetite profile in response to
15 e was to determine ad libitum energy intake, body weight changes, appetite profile, and nitrogen bala
16 rogram may lose fat that is not reflected in body weight changes because of concurrent gains in fat-f
17                              In consequence, body weight changed by +2.90 and -3.18 kg.
18 pioid receptor genes altered food intake and body weight changes following 24 h of food deprivation i
19            The mean difference in percentage body weight change for liraglutide, 3.0 mg, vs placebo w
20 n food intake and corresponding increases in body weight change for the 24-96 hr observation period.
21               At week 68, the estimated mean body weight change from baseline was -16.0% for semaglut
22   In the 52-week completer population, total body weight change from baseline was -22.1 +/- 2.1 kg (P
23             With continued semaglutide, mean body weight change from week 20 to week 68 was -7.9% vs
24 ical modeling of human energy regulation and body weight change has recently reached the level of sop
25 ty, and fertility) and metabolic parameters (body weight changes, hormone levels, body fat content, a
26 ciation between beverage consumption and 5-y body weight change in 2294 adolescents.
27 ing the association of 100% fruit juice with body weight change in children and adults were included.
28 ompared with a control diet independently of body weight change in individuals with features of the m
29  between animal protein intake and long-term body weight change in middle-aged Europeans but does not
30                     Sex-specific, long-term, body weight change in persons with human immunodeficienc
31 ergy intake, duration of follow-up, baseline body weight, change in body weight, and waist circumfere
32 r that had a primary or secondary outcome of body weight change, included at least 50 participants pe
33           Results show that the anorexia and body weight changes induced by administration of exogeno
34 d with inflammation, but the extent to which body weight changes influence inflammation during human
35                   We found no alterations in body weight changes, lifespan, RotaRod performances, gri
36 rat) into the CeA and home-cage food intake, body weight change, microstructural analysis of food int
37 mediator have yielded somewhat disappointing body weight changes, often leading to the hormone/mediat
38 le grains for refined grains, independent of body weight changes, on energy-metabolism metrics and gl
39                                              Body weight changed significantly throughout the 15 wk,
40 itis intensity was investigated by measuring body weight changes, stool consistency/bleeding and colo
41 duces fasting blood glucose independently of body weight changes, suggesting that adropin suppresses
42 ct of ginsenoside Re was not associated with body weight changes, suggesting that other constituents
43 ved from the dose-response analyses that the body weight change that follows MC treatments is seconda
44   Hydration status was assessed by measuring body weight change, urine specific gravity, and urine an
45 take within each 4-y interval and concurrent body weight changes using multivariable linear regressio
46                                              Body weight change was described by using linear mixed m
47                                              Body weight change was not significantly different in th
48                                         Mean body weight changes were -0.8, 0.0, and 0.2 kg for place
49                             For example, net body weight changes were -0.92 kg (95% CI: -1.58, -0.25)
50 -X and DEX on intraocular pressure (IOP) and body weight changes were also evaluated.
51                              Food intake and body weight changes were also monitored and yoked, pair-
52                                              Body weight changes were associated with changes in live
53                        Daily food intake and body weight changes were measured during twice-daily inj